Skip to main content

Immune-Mediated Necrotizing Myopathy

0
Pipeline Programs
1
Companies
3
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Grifols
GrifolsNEW YORK, NY
1 program
Gamunex-CPHASE_23 trials
Active Trials
NCT07582432Recruiting49Est. Aug 2028
NCT07540221Recruiting40Est. Dec 2027
NCT04450654Withdrawn0Est. Jul 2022

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
2027
2028
GrifolsGamunex-C
GrifolsGamunex-C
GrifolsGamunex-C

Clinical Trials (3)

Total enrollment: 89 patients across 3 trials

NCT07582432GrifolsGamunex-C

A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma

Start: Apr 2026Est. completion: Aug 202849 patients
Phase 3Recruiting
NCT07540221GrifolsGamunex-C

A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Start: Apr 2026Est. completion: Dec 202740 patients
Phase 3Recruiting
NCT04450654GrifolsGamunex-C

Monotherapy IVIG Gamunex-C for HMG-CoA Reductase Auto-Antibody Positive Necrotizing Myopathy Treatment (The MIGHT Trial)

Start: May 2022Est. completion: Jul 20220
Phase 2Withdrawn

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 89 patients
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.